Tool could Improve Success in Translating Drugs from Animal Studies to Humans

Tool could Improve Success in Translating Drugs from Animal Studies to Humans

SEMrush
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.

Scientists might be able to catch problems like this one earlier in the drug development process, when drugs move from testing in animals to clinical trials, with a new computational model developed by researchers from Purdue University and Massachusetts Institute of Technology.

[automaticbacklinks]